The non-invasive evaluation of heart function in patients with an acute myocardial infarction: The role of impedance cardiography by Lewicki, Lukasz et al.
  
ONLINE FIRST
This is a provisional PDF only. Copyedited and fully formatted version will be made available soon.
ISSN: 1897-5593
e-ISSN: 1898-018X
The non-invasive evaluation of heart function in patients with
an acute myocardial infarction: The role of impedance
cardiography
Authors:  Lukasz Lewicki, Marta Fijalkowska, Maciej Karwowski, Konrad Siebert,
Grzegorz Redlarski, Aleksander Palkowski, Radoslaw Targonski, Janusz Siebert
DOI: 10.5603/CJ.a2019.0098
Article type: Original articles
Submitted: 2018-08-01
Accepted: 2019-10-01
Published online: 2019-10-21
This article has been peer reviewed and published immediately upon acceptance.
It is an open access article, which means that it can be downloaded, printed, and distributed freely,
provided the work is properly cited.
Articles in "Cardiology Journal" are listed in PubMed. 
Powered by TCPDF (www.tcpdf.org)
 1 
The non-invasive evaluation of heart function in patients with an acute myocardial 
infarction: The role of impedance cardiography 
Running title: Impedance cardiography in acute myocardial infarction 
 
 
Lukasz Lewicki1, Marta Fijalkowska2, Maciej Karwowski2, Konrad Siebert1, Grzegorz 
Redlarski3, Aleksander Palkowski3, Radoslaw Targonski2, Janusz Siebert1, 4 
 
1University Center for Cardiology, Gdansk, Poland 
2Pomeranian Cardiology Centers, Wejherowo, Poland 
3Department of Mechatronics and High Voltage Engineering, Gdansk University of 
Technology, Gdansk, Poland 
4Department of Family Medicine, Medical University of Gdansk, Poland 
 
 
Address for correspondence: Lukasz Lewicki, MD, PhD, University Center for Cardiology, 
ul. Dębinki 2, 80–211 Gdańsk, Poland, e-mail: luklewicki@gmail.com 
 
 
Abstract 
Background: The purpose of this study was to analyze hemodynamic changes in patients 
treated with percutaneous coronary intervention (PCI) at an early stage of acute myocardial 
infarction (AMI) and at one-month follow-up. 
Methods: Patients with AMI (n = 27) who underwent PCI were analyzed using impedance 
cardiography (ICG). ICG data were collected continuously (beat by beat) during the whole 
PCI procedure and thereafter at every 60 s  for the next 24 h. Blood pressure was taken every 
10 min and stored for analysis. Additionally the following parameters were measured: cardiac 
index (CI), stroke volume index (SVi), left cardiac work index (LCWi), contractility index 
(CTi), ventricular ejection time (VET), systemic vascular resistance index (SVRi), thoracic 
fluid content index (TFCi) and heart rate (HR).  
Results: In the first 24 h after PCI all the contractility parameters including CI, SVi, LCWi, 
CTi and VET significantly decreased, whereas HR, SVRi and TFCi increased compared to 
baseline. All of the parameters examined got normalized at one month. The CI, SVi, LCWi, 
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CTi, SVRi did not significantly differ from baseline, however the HR and VET were 
significantly lower compared to first day after PCI. 
Conclusions: 1. Cardiac performance deteriorates early after PCI and normalizes after one 
month in patients with an AMI. 2. ICG is useful for hemodynamic monitoring of AMI 
patients during and after invasive therapy.  
Key words: impedance cardiography, acute myocardial infarction, hemodynamics, 
percutaneous coronary intervention 
 
 
Introduction 
Although a commonly used early reperfusion treatment in AMI, by using either 
thrombolysis or primary percutaneous coronary intervention (PCI) significantly limits 
myocardial damage, the process of reperfusion itself may induce so called ischemic 
reperfusion injury (IRI) [1–4]. The pathogenesis of this phenomenon is complex and may be 
related to myocardial stunning [5], microvascular obstruction [6–8], lethal myocardial 
reperfusion injury [3] or reperfusion-induced ventricular arrhythmias [9]. 
Despite significant progress in PCI technology and antiplatelet therapy, the IRI 
remains an important therapeutic target in patients with AMI. Therefore, it is fundamental to 
stratify the risk at an early stage of AMI and to evaluate heart function in a real-time manner.  
Recently used monitoring of patient’s hemodynamic profile is based mainly on 
electrocardiographic (ECG) analysis, blood pressure (BP) monitoring and bedside 
echocardiography (TTE). The three-dimensional ultrasonography and magnetic resonance 
imaging are accurate in the evaluation of myocardial function, but they involve high costs, 
and require qualified personnel. An invasive heart catheterization with Swan-Ganz does not 
occur in the guidelines because of its complexity and complication risk. Therefore, in patients 
requiring intensive care after AMI, non-invasive hemodynamic monitors such as impedance 
cardiography (ICG) might be an interesting option in the treatment strategy. 
The ICG is a non-invasive diagnostic method based on the detection of thoracic 
electrical bio-impedance across the thorax during systole and diastole of the heart. The ICG 
allows monitoring of hemodynamic parameters, comprising for instance: stroke volume (SV), 
cardiac output (CO), systemic vascular resistance (SVR), thoracic fluid content (TFC) and 
many others. 
Trans-thoracic bio-impedance is a technique, which quantifies mechanical activity of 
the heart instead of its electrical activity. A fundamental principle of trans-thoracic bio-
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impedance is that it uses direct measurement of baseline impedance, ventricular ejection time, 
heart rate, and early diastolic filling ratio. These parameters are measured  and used to 
compute other hemodynamic parameters.  
Application of ICG for the determination of hemodynamic parameters is based on the 
following principle: different tissues, i.e. muscles, bones, fat and blood have specific electrical 
properties. Among them, the blood is the most conductive body tissue in the thorax. The 
differences in thoracic electrical impedance are essentially created by changes in the velocity 
and blood volume in the aorta. 
The clinical use of ICG has been described recently. 
In patients after off-pump coronary artery bypass grafting, the findings obtained from 
ICG were correlated with B-type natriuretic peptide (BNP) levels and TTE measurements for 
the evaluation of cardiac hemodynamic changes during perioperative period [10]. 
Louvaris et al. [11] compared concurrent CO measurements captured by ICG (COIC ) 
and by the indocyanine green dye dilution method (CODD ) in patients with chronic 
obstructive pulmonary disease (COPD). They found a strong correlation between COIC  and 
CODD. Malek et al. [12] analyzed hemodynamic data obtained from ICG, TTE and gas 
exchange analysis during rest and exercise among wheelchair rugby players. Their analysis 
showed a good correlation between the methods, however, interestingly, a CO was 
overestimated by ICG. 
Last but not least, an impaired hemodynamic response to exercise in hypertensive 
females with dyspnea was proved by ICG [13].  
Thus, the aim of the present study was to evaluate the dynamic changes in  the 
hemodynamic profile of patients during an early stage of AMI and at one-month follow-up. 
 
Methods 
Herein, 27 AMI patients were included. The ECG of 20 patients revealed on 
admission persistent ST-elevation myocardial infarction (STEMI) and the other 7 were 
diagnosed with non-ST-elevation myocardial infarction (NSTEMI). All patients underwent 
urgent coronary catheterization with subsequent PCI. 
The ICG was performed with PhysioFlow Q-Link (Manatec Biomedical, Paris, France) 
and TTE examination was obtained by using Aloka Prosound Alpha 6. 
 
Bioimpednace measurements  
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The PhysioFlow® Q-LinkTM is a noninvasive hemodynamic evaluation system to assess 
patient cardiovascular state using analyses of trans-thoracic bio-impedance signals.  
PhysioFlow System measures the change in impedance by injecting a high frequency 
alternating electrical current (66 kHz) of low magnitude (4.5 mA peak to peak) towards the 
thorax between two electrodes positioned on the neck and another two positioned on the 
xiphoid process. The use of a high frequency current eliminates the risk of interference with 
heart and brain bioelectrical activity. 
For measurement at rest the electrodes were placed on the thorax as presented in Figure 1. 
Impedance cardiography was initiated in the cathlab just before a coronary 
catheterization. Four ICG and two ECG pre-gelled electrodes were placed accordingly: two 
(Z1, Z2) on the left side of patient’s neck, one (Z3) at the level of the xiphoid and the last one 
(Z4) just to the right of Z3. The ICG data were collected continuously (beat by beat) during 
the whole PCI procedure and later, after PCI, the recorded signal was averaged for each 10 s 
during the next 24 h automatically. BP was taken each 10 min during PCI and stored for 
analysis. The following parameters were measured beat-to-beat continuously: cardiac index 
(CI [l/min/m2]), stroke volume index (SVi [mL/m2]), left cardiac work index (LCWi 
[kg∙m/m2]), contractility index (CTi), ventricular ejection time (VET [ms]), systemic vascular 
resistance index (SVRi [dyn∙s/cm5∙m2]), thoracic fluid content index (TFCi [1/kΩ∙m2]) and 
heart rate (HR [1/min]). Specific calculations conducted as part of a further analysis were 
based on the values obtained in the supine position. The quality of all measurements was high, 
and no relevant errors were noted. 
 
Echocardiographic measurements 
The measurements were taken in 24 h after AMI and at the follow-up visit. The 
examinations were taken as recommended by the European Society of Cardiology and 
American Heart Association. Patients were imaged in the left lateral decubitus position. 
Images were obtained in parasternal and apical projections. A left ventricular ejection fraction 
(LVEF) was determined by using the Simpson method for biplane assessment. All 
examinations were performed by the same investigator. 
Every patient has been scheduled for a follow-up visit after 30 days in order to 
perform TTE, clinical examination and ICG hemodynamics was continuous for a 20 min 
measurement.  
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Statistical analysis 
To test the validity of the data a series of statistical tests were prepared including: the 
Shapiro-Wilk test and ANOVA statistic. All statistical analysis presented was conducted 
using Python programming language (v. 3.6.1) and a selection of supporting mathematical 
packages: NumPy and Pandas for basic mathematical operations, and SciPy for all relevant 
statistical computations. Plots were generated using Python programming language (v. 3.6.1) 
and the Matplotlib package. 
 
Results  
In the group observed there were more males than females (Table 1). The majority of 
patients were hospitalized with STEMI and the most common culprit lesions were right 
coronary artery (RCA) or left anterior descending branch (LAD). All patients underwent PCI. 
A good angiographic result (TIMI 3) was achieved in all but two subjects. 
The results are presented in Figure 2 and Table 2. On the first day after PCI, a 
significant decrease in hemodynamic parameters describing heart contractility was observed: 
CI, LCWi, CTi and VET. The contractility index (CTI) reflects an amplitude of the first 
derivative dz/dt was significantly decreased during first day after PCI (p < 0.002) and had 
increased at the time of follow-up (p < 0.004). 
In contrast, during the same period, an increase in HR and SVRi was noticed during 
the first day after PCI compared to baseline, but decreased after 1 month. 
At follow-up CI, SVi, LCWi, CTi, SVRi did not differ from baseline. Heart rate 
decreased and ventricular ejection time was significantly longer compared to the first day 
after PCI.  
The LVEF was significantly higher compared to 24 h after PCI and at follow-up 
(39.4% ± 9 vs. 52.6% ± 5, p < 0.01). 
 
Discussion 
In this single-center study  changes were analyzed in the hemodynamic profile of AMI 
patients by using ICG. Although a good correlation between impedance diagnostics and 
invasive assessment of cardiac output and systemic vascular resistance has been reported [10, 
11], thus far, data is mostly limited to heart failure [12–15] and with only a few AMI subsets 
examined [16–18]. 
Herewith, despite an early and successful primary PCI this study presents that, a 
contractility of a myocardium did not improve immediately and, interestingly, it became 
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worse during the first day. This observation was followed by an increase in systemic vascular 
resistance and HR, which could be explained as a compensatory reaction for maintaining 
cardiac output in consideration of decreased cardiac contractility. Chen et al. [16] observed 
that HR and BP significantly decreased 7 days after primary PCI, whereas other ICG 
parameters remained unchanged in an AMI setting. In contrast to the present findings, that 
were focused on the very early stage of AMI, including the first hours after PCI — in a study 
by Chen et al. [16], the authors might have overlooked the early changes. 
The observed transient hemodynamic deterioration may appear as a consequence of 
“myocardial stunning”. This phenomenon is described as a reversible post-ischemic 
contractile dysfunction, one of the forms of IRI. All parameters that characterized myocardial 
contractility returned to a normal range after 1 month, which corresponds to the reversible 
nature of myocardial stunning. 
Decreased HR at follow up vs. baseline could be explained either by contractility 
improvement, or as well as by b-blockers routinely included in  treatment.  
The TFCi that reflects thoracic fluid content, significantly decreased at follow-up in 
comparison to baseline. The transient elevation of this parameter observed on the first day, 
post PCI, may be related to common in-hospital fluid overload: contrast agent, intravenous 
saline etc. Malfatto et al. [19] showed good correlation between the TFC and an increased 
pulmonary capillary wedge pressure. The higher TFCi may also reflect an exacerbation of left 
ventricle failure. In another analysis, Sadauskas et al. [12] found a moderately strong 
relationship between BNP and TFCI. 
The pathogenesis of IRI is still not completely understood. Several mechanisms have 
been proposed: Ca2+ overload, oxidative stress or inflammatory response [1, 20]. 
As IRI is a serious clinical problem among AMI patients, it requires detailed 
monitoring of the hemodynamics during hospitalization on intensive coronary care units 
(ICCU). ICG seems to be an easy and useful method for precise monitoring of patients with 
AMI on ICCU. Herewith, is reported a detailed pattern of changes in ICG hemodynamic 
profile of patients early after PCI and at 30 day follow-up. This method is potentially helpful 
in modifying intensive therapy with fluids or inotropes in clinical routine. 
 
Conclusions 
1. Despite a successful PCI, cardiac contractility deteriorates early after PCI and normalizes 
after one month in AMI patients. 
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2. Impedance cardiography is useful for non-invasive hemodynamic monitoring in ICCU 
patients, providing an optimal hemodynamic profile and a better understanding of myocardial 
stunning processes. 
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Table 1. The clinical and angiographic data of 27 patients with an acute myocardial infarction 
(MI). 
Age [years] 62.3 ± 13.4 
Male/female 17/10 
BMI [kg/m2] 27.7 ± 4.8 
STEMI/NSTEMI 20/7 
Arterial hypertension 14 
Diabetes 9 
History of previous MI 2 
REF-HF 9 
History of stroke 4 
COPD 4 
History of previous PCI 4 
LVEF at 1st day 39.4 ± 9.2 
LVEF at follow up 52.5 ± 5.4 
Infarct related artery: 
LM 
LAD 
CX 
RCA 
 
2 
11 
2 
12 
TIMI 3 after PCI 25 
BMI — body mass index; STEMI — ST segment elevation myocardial infarction; NSTEMI — non ST segment 
elevation myocardial infarction; REF-HF — reduced ejection fraction heart failure; COPD — chronic 
obstructive pulmonary disease; PCI — percutaneous coronary intervention; LVEF — left ventricular ejection 
fraction; LM — left main coronary artery; LAD — left artery descending artery; CX — circumflex artery; RCA 
— right coronary artery; TIMI — thrombolysis in myocardial infarction scale 
 
 
 
 
Table 2. Hemodynamic profile during the early stage of acute myocardial infarction and at 
the one-month follow-up in 27 patients.  
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Parameter Measurement day Mean ± SD P 
TFCi [1/kΩ∙m2] 1/ Just before PCI 9.6 ± 2.2 1 vs. 2: p = 0.62 
1 vs. 3: p = 0.01 
2 vs. 3: p = 0.006 
2/ 1st day after PCI 9.9 ± 2.6 
3/ 30 days after PCI 8.4 ± 0.9 
HR [1/min] 1/ Just before PCI 79.5 ± 12.5 1 vs. 2: p = 0.003 
1 vs. 3: p = 0.01 
2 vs. 3: p = 6.94E-06 
2/ 1st day after PCI 95.1 ± 22.5 
3/ 30 days after PCI 70.5 ± 12.2 
SVi [mL/m2] 1/ Just before PCI 42.0 ± 14.1 1 vs. 2: p = 0.01 
1 vs. 3: p = 0.098  
2 vs. 3: p =3.75E-05 
2/ 1st day after PCI 31.5 ± 14.5 
3/ 30 days after PCI 48.0 ± 12.3 
CI [l/min/m2] 1/ Just before PCI 3.3 ± 1.0 1 vs. 2: p = 0.025 
1 vs. 3: p = 0.669  
2 vs. 3: p = 0.016 
2/ 1st day after PCI 2.7 ± 0.9 
3/ 30 days after PCI 3.2 ± 0.5 
VET [ms] 1/ Just before PCI 292.9 ± 49.1 1 vs. 2: p =9.93E-05 
1 vs. 3: p = 0.008 
2 vs. 3: p = 1.01E-07 
2/ 1st day after PCI 215.6 ± 81.7 
3/ 30 days after PCI 331.0 ± 52.4 
LCWi [kg∙m/m2] 1/ Just before PCI 4.4 ± 1.4 1 vs. 2: p = 0.001 
1 vs. 3: p = 0.969 
2 vs. 3: p = 0.0008 
2/ 1st day after PCI 3.2 ± 1.3 
3/ 30 days after PCI 4.4 ± 1.3 
SVRi 
[dyn∙s/cm5∙m2] 
1/ Just before PCI 2506.3 ± 620.4 1 vs. 2: p = 0.02 
1 vs. 3: p = 0.03 
2 vs. 3: p = 0.02 
2/ 1st day after PCI 3663.7 ± 1296.5 
3/ 30 days after PCI 2616.2 ± 443.8 
SVR [dyn∙s/cm5] 1/ Just before PCI 1282.2 ± 331.0 1 vs. 2: p = 0.02 
1 vs. 3: p = 0.03 
2 vs. 3: p = 0.02 
2/ 1st day after PCI 1899.0 ± 673.8 
3/ 30 days after PCI 1482.8 ± 534.5 
SABP [mmHg 1/ Just before PCI 132.5 ± 25.7 1 vs. 2: p = 0.41 
1 vs. 3: p = 0.19 
2 vs. 3: p = 0.02 
2/ 1st day after PCI 127.0 ± 21.4 
3/ 30 days after PCI 141.7 ± 24.0 
DABP [mmHg] 1/ Just before PCI 78.0 ± 14.9 1 vs. 2: p = 0.18 
1 vs. 3: p = 0.96 
2 vs. 3: p = 0.12 
2/ 1st day after PCI 73.1 ± 10.7 
3/ 30 days after PCI 77.8 ± 10.5 
MABP [mmHg] 1/ Just before PCI 101.5 ± 18.6 1 vs. 2: p = 0.24 
1 vs. 3: p = 0.48 2/ 1st day after PCI 96.1 ± 14.0 
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3/ 30 days after PCI 104.9 ± 14.6 2 vs. 3: p = 0.03 
Hemodynamic parameters measured by Impedance Cardiography. The p-values are based on the AVOVA test. 
CI — cardiac index [l/min/m²]; CO — cardiac output [l/min]; SVRi — systemic vascular resistance index 
[dyn∙s/cm5∙m2]; SVR — systemic vascular resistance [dyn∙s/cm5]; HR —heart rate [1/min]; SVi — stroke 
volume index [mL/m2]; LCWi —  cardiac work index [kg∙m/m2]; VET— ventricular ejection time [ms]; TFCi 
— thoracic fluid content index [1/kΩ∙m2], SABP — systolic arterial blood pressure [mmHg], DABP — diastolic 
arterial blood pressure [mmHg]; MABP — mean arterial blood pressure [mmHg] 
 
 
 
Figure 1. The position current (Z1, Z4) and voltage (Z2, Z3) electrodes on the thorax —
scheme and original photo. The electrodes were positioned on the neck, the back at the level 
of the xiphoid on the left-hand side of the spine, the left-hand side lower ribs and the right 
clavicle. 
 
Figure 2. Comparison of hemodynamic parameters in 27 patients with myocardial infarction 
recorded before percutaneous coronary intervention (PCI) and at 1 and 30 days after PCI. 
 
Figure 3. Averaged electrocardiogram and impedance signal in a patient during percutaneous 
coronary intervention. 
 
Figure 4. Averaged electrocardiogram and impedance signal in a patient after percutaneous 
coronary intervention. 
 
Figure 5. Averaged electrocardiogram and impedance signal in a patient 30 days after 
percutaneous coronary intervention. 
 
 





